Values Added Financial’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$832K Sell
9,634
-20
-0.2% -$1.78K 0.29% 56
2026
Q2
$873K Buy
9,654
+56
+0.6% +$4.69K 0.32% 57
2026
Q1
$769K Buy
9,598
+204
+2% +$16.8K 0.32% 56
2025
Q4
$801K Buy
9,394
+42
+0.4% +$3.45K 0.34% 54
2025
Q3
$727K Sell
9,352
-56
-0.6% -$4.38K 0.32% 56
2025
Q2
$736K Sell
9,408
-45
-0.5% -$3.36K 0.36% 55
2025
Q1
$685K Buy
9,453
+91
+1% +$6.51K 0.38% 52
2024
Q4
$693K Buy
9,362
+16
+0.2% +$1.12K 0.4% 47
2024
Q3
$617K Buy
9,346
+23
+0.2% +$1.67K 0.39% 45
2024
Q2
$861K Buy
9,323
+21
+0.2% +$1.86K 0.62% 31
2024
Q1
$889K Hold
9,302
– – 0.69% 29
2023
Q4
$709K Sell
9,302
-16
-0.2% -$1.11K 0.58% 33
2023
Q3
$646K Buy
9,318
+18
+0.2% +$1.45K 0.59% 35
2023
Q2
$877K Buy
+9,300
New +$808K 0.82% 28

Other funds holding EW

Values Added Financial's EW Position: Q3 2026 in Review

Values Added Financial reduced its Edwards Lifesciences (EW) stake by 0.21% in Q3 2026, selling an estimated $1.78K and leaving 9,634 shares worth $832K. The position accounts for 0.29% of the portfolio, ranked #56.

Values Added Financial first reported a position in EW in Q2 2023 and has held it in 14 quarters since. The position peaked at $889K in Q1 2024. 481 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Values Added Financial held 9,634 shares of Edwards Lifesciences worth $832K as of Q3 2026.
  • Values Added Financial sold 20 Edwards Lifesciences shares in Q3 2026, an estimated $1.78K.
  • Edwards Lifesciences made up 0.29% of Values Added Financial's portfolio in Q3 2026, its #56 holding.
  • Values Added Financial first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 14 quarters since.
  • Values Added Financial's Edwards Lifesciences position peaked at $889K in Q1 2024.
  • 481 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Values Added Financial's 13F filing for Q3 2026, filed 28 Oct 2026.